Cargando…

Characterization of a BMS-181174-resistant human bladder cancer cell line.

This study was undertaken to elucidate the mechanism of cellular resistance to BMS-181174, a novel analogue of mitomycin C (MMC), in a human bladder cancer cell line. The BMS-181174-resistant variant (J82/BMS) was established by repeated continuous exposures of parental cells (J82) to increasing con...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xia, H., Bleicher, R. J., Hu, X., Srivastava, S. K., Gupta, V., Zaren, H. A., Singh, S. V.
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1997
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2227981/ https://www.ncbi.nlm.nih.gov/pubmed/9275022

Ejemplares similares

Phase I study of the mitomycin C analogue BMS-181174.
por: Macaulay, V. M., et al.
Publicado: (1998)

Dapagliflozin: BMS 512148; BMS-512148
Publicado: (2012)

Construction of the MPI BMS Prototype Chamber
por: Bratzler, U, et al.
Publicado: (1997)

Crystal structures of trimeric HIV Env with entry inhibitors BMS-378806 and BMS-626529
por: Pancera, Marie, et al.
Publicado: (2017)

Barrel-muon-spectrometer: BMS
Publicado: (2005)

Barrel-muon-spectrometer: BMS
Publicado: (2005)

Barrel-muon-spectrometer: BMS
Publicado: (2005)

Barrel-muon-spectrometer: BMS
Publicado: (2005)

Barrel-muon-spectrometer: BMS
Publicado: (2005)

Barrel-muon-spectrometer: BMS
Publicado: (2005)

Barrel-muon-spectrometer: BMS
Publicado: (2005)

Role of Mitochondrial Toxicity in BMS-986094-Induced Toxicity
por: Feng, Joy Y., et al.
Publicado: (2017)

Dasatinib (BMS-35482) potentiates the activity of gemcitabine and docetaxel in uterine leiomyosarcoma cell lines
por: Lopez-Acevedo, Micael, et al.
Publicado: (2014)

BMS-599626, a Highly Selective Pan-HER Kinase Inhibitor, Antagonizes ABCG2-Mediated Drug Resistance
por: Ashar, Yunali V., et al.
Publicado: (2020)

BMS1 Is Mutated in Aplasia Cutis Congenita
por: Marneros, Alexander G.
Publicado: (2013)

Effect of BMS-470539 on lipopolysaccharide-induced neutrophil activation
por: Lee, Seongheon, et al.
Publicado: (2020)

Identification and Preclinical Pharmacology of the γ-Secretase Modulator BMS-869780
por: Toyn, Jeremy H., et al.
Publicado: (2014)

A Behaviour Monitoring System (BMS) for Ambient Assisted Living
por: Eisa, Samih, et al.
Publicado: (2017)

The effects of BMS-470539 on lipopolysaccharide-induced acute lung injury
por: Jang, Eun-A, et al.
Publicado: (2019)

Comparison of coronary DES and BMS in octogenarians: A systematic review and meta-analysis
por: Gao, Lei, et al.
Publicado: (2013)

Differential Effects of IGF-1R Small Molecule Tyrosine Kinase Inhibitors BMS-754807 and OSI-906 on Human Cancer Cell Lines
por: Fuentes-Baile, María, et al.
Publicado: (2020)

Proteome characterization of a human urothelial cell line resistant to the bladder carcinogen 4-aminobiphenyl
por: Pastorelli, Roberta, et al.
Publicado: (2007)

The Effectiveness and Adverse Events of Amitriptyline and Aripiprazole in Very Elderly Patients With BMS
por: Watanabe, Motoko, et al.
Publicado: (2022)

Identification and Preclinical Evaluation of the Bicyclic Pyrimidine γ-Secretase Modulator BMS-932481
por: Boy, Kenneth M., et al.
Publicado: (2019)

Characterisation of a navelbine-resistant bladder carcinoma cell line cross-resistant to taxoids.
por: Debal, V., et al.
Publicado: (1994)

BMS-345541 inhibits airway inflammation and epithelial-mesenchymal transition in airway remodeling of asthmatic mice
por: Zhu, Xiaohua, et al.
Publicado: (2018)

BMS-754807 is cytotoxic to non-small cell lung cancer cells and enhances the effects of platinum chemotherapeutics in the human lung cancer cell line A549
por: Franks, S. Elizabeth, et al.
Publicado: (2016)

Mechanism of differential sensitivity of human bladder cancer cells to mitomycin C and its analogue.
por: Xu, B. H., et al.
Publicado: (1994)

Branebrutinib (BMS-986195), a Bruton’s Tyrosine Kinase Inhibitor, Resensitizes P-Glycoprotein-Overexpressing Multidrug-Resistant Cancer Cells to Chemotherapeutic Agents
por: Wu, Chung-Pu, et al.
Publicado: (2021)

Cases Reported by Surgeon R. D. Murray, M.B. B.M.S.
Publicado: (1878)

Structure-activity relationship of BMS906024 derivatives for Cryptosporidium parvum growth inhibition
por: Lee, Seungheon, et al.
Publicado: (2023)

BMS-708163 and Nilotinib restore synaptic dysfunction in human embryonic stem cell-derived Alzheimer’s disease models
por: Nishioka, Hisae, et al.
Publicado: (2016)

Phase I trial of the novel taxane BMS-184476 administered in combination with carboplatin every 21 days
por: Bilenker, J H, et al.
Publicado: (2004)

Experience with Using the Sensewear BMS Sensor System in the Context of a Health and Wellbeing Application
por: Jones, Val, et al.
Publicado: (2011)

Violations of International Code of Breast‐milk Substitutes (BMS) in commercial settings and media in Bangladesh
por: Sheikh, Sifat P., et al.
Publicado: (2022)

BMS794833 inhibits macrophage efferocytosis by directly binding to MERTK and inhibiting its activity
por: Bae, Seung-Hyun, et al.
Publicado: (2022)

Development of a BIM-based bridge maintenance system (BMS) for managing defect data
por: Li, Sai, et al.
Publicado: (2023)

PAR4 (Protease-Activated Receptor 4) Antagonism With BMS-986120 Inhibits Human Ex Vivo Thrombus Formation
por: Wilson, Simon J., et al.
Publicado: (2018)

Pharmacodynamic activity of BMS-986156, a glucocorticoid-induced TNF receptor-related protein agonist, alone or in combination with nivolumab in patients with advanced solid tumors
por: Wang, R., et al.
Publicado: (2023)

Characterization of Resistance to Rhabdovirus and Retrovirus Infection in a Human Myeloid Cell Line
por: Boso, Guney, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_pkn0mkhj66ihlch49gvm5ksbbb